Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
Is a |
difenoxinhydrochlorid |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
Is a |
Product containing atropine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
Is a |
Product containing atropine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Atropine (substance) |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Difenoxin hydrochloride (substance) |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
Is a |
atropinsulfat + diphenoxylathydrochlorid |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Atropine sulfate |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
Has manufactured dose form |
oral væske |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Diphenoxylate hydrochloride |
false |
Inferred relationship |
Some |
|
|
atropinsulfat 0,025 mg + diphenoxylathydrochlorid 2,5 mg væske |
Is a |
Product containing atropine in oral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|